✦ LIBER ✦

Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function

✍ Scribed by Suzanne K. Swan; James F. Baker; Richard Free; Richard M. Tucker; Bruce Barron; Richard Barr; Steve Seltzer; G. Scott Gazelle; Kenneth R. Maravilla; William Barr; Gary R. Stevens; Lawrence J. Lambrecht; Joseph A. Pierro

Book ID: 101311953
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 49 KB
Volume: 9
Category: Article
ISSN: 1053-1807
DOI: 10.1002/(sici)1522-2586(199902)9:2<317::aid-jmri25>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views